Bank of Montreal
MIRM icon

Bank of Montreal’s Mirum Pharmaceuticals MIRM Stock Holding History

Bank of Montreal’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-56,386
Closed -$5.21M – 3976
2026
Q1 		$5.21M Sell
56,386
-683
-1% -$64.3K ﹤0.01% 1307
2025
Q4 		$4.51M Buy
57,069
+26
+0% +$1.87K ﹤0.01% 1362
2025
Q3 		$4.18M Hold
57,043
– – ﹤0.01% 1370
2025
Q2 		$2.9M Buy
57,043
+703
+1% +$31.3K ﹤0.01% 1450
2025
Q1 		$2.54M Buy
56,340
+3,842
+7% +$181K ﹤0.01% 1420
2024
Q4 		$2.17M Buy
52,498
+9,500
+22% +$396K ﹤0.01% 1510
2024
Q3 		$1.67M Hold
42,998
– – ﹤0.01% 1785
2024
Q2 		$1.49M Sell
42,998
-2,274
-5% -$59.6K ﹤0.01% 1805
2024
Q1 		$1.32M Sell
45,272
-4,519
-9% -$124K ﹤0.01% 1856
2023
Q4 		$1.62M Buy
+49,791
New +$1.51M ﹤0.01% 1793
2021
Q2 		– Sell
-166
Closed -$3K – 4440
2021
Q1 		$3K Sell
166
-624
-79% -$11.9K ﹤0.01% 4828
2020
Q4 		$15K Buy
790
+551
+231% +$10.8K ﹤0.01% 4545
2020
Q3 		$4K Sell
239
-161
-40% -$3.46K ﹤0.01% 4511
2020
Q2 		$8K Buy
+400
New +$6.68K ﹤0.01% 4275
2020
Q1 		– Sell
-339
Closed -$8K – 4459
2019
Q4 		$8K Buy
+339
New +$3.61K ﹤0.01% 4622

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal's MIRM Position: Q2 2026 in Review

Bank of Montreal sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 56,386 shares — an estimated $5.21M sold.

Bank of Montreal first reported a position in MIRM in Q4 2019 and held it in 15 quarters. The position peaked at $5.21M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Bank of Montreal reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Bank of Montreal sold 56,386 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.21M.
  • Bank of Montreal first reported a position in Mirum Pharmaceuticals in Q4 2019 and held it in 15 quarters.
  • Bank of Montreal's Mirum Pharmaceuticals position peaked at $5.21M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.